There is a lot of research taking place into all types of Cancer.

Please be aware that each individual is different and your cancer may not respond to the same treatment someone else has been given.

The following websites give you further information into some of the research currently happening. If you have any concerns you should discuss it with your healthcare professional.

National Institute for Health Research (NIHR)
The NIHR is the nation’s largest funder of health and care research and provides the people, facilities and technology that enable research to thrive. The NIHR works in partnership with the NHS, universities, local government, other research funders (including industry and charities), patients and the public to improve the health and wealth of the nation. Their pages take you to the latest news and blogs about Cancer.

Cancer Research UK
Cancer Research UK funds research into all types of Cancer and these pages take you to its work specifically with breast cancer.

Oncology Open Access Research
Open access research showcases journal news, collections, highlights and recent campaigns from our open access journals, as selected by their editors.

This Add-Aspirin trial will recruit 11,000 participants to help find out whether regular aspirin use after treatment for an early stage cancer can prevent the cancer from coming back and preventing deaths.

This is a trial looking at a test to predict who might benefit from chemotherapy for breast cancer (OPTIMA)

The POSNOC  trial is looking at treatment to the armpit after surgery to remove early stage breast cancer. The trial is for women whose breast cancer has spread to 1 or 2 lymph nodes

POSH is a study, which looked at how well treatment worked for women who were diagnosed with breast cancer when they were aged between 18 and 40. It was for both women with an inherited genetic change that increases the risk of breast cancer, and women without. The study was supported by Cancer Research UK. This trial is now closed.

POETIC is a phase III, multicentre, randomised trial for postmenopausal women with ER/PR positive invasive breast cancer to determine whether 2 weeks perioperative aromatase inhibitor (AI) therapy before and after surgery improves outcome compared with standard adjuvant therapy alone. This trial is closed to recruitment and patients who took part are being followed-up.

REACT is a trial which looked at using celecoxib for women with breast cancer. This trial is now closed and is awaiting results.



Last Modified: 11:28am 12/02/2020